Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bayer Schering Pharma contraceptive launched in Europe

Bayer Schering Pharma contraceptive launched in Europe

8th September 2008

Bayer Schering Pharma has announced the launch of its new low-dose orally-administered contraceptive Yaz in Europe.

The company said its new dosing regimen for the drug, which uses 24 days of active hormone tablets and four days of hormone-free pills has been shown to reduce fluctuations.

Yaz contains 3mg of progestin drospirenone combined with 0.02mg of ethinyl estradiol.

Bayer said overall satisfaction with this pill is very high in the US, where the drug has been available since 2006, with the compound becoming the country’s fastest branded orally-administered contraceptive.

The drug will be available in some European countries from the start of this month, with further launches occurring at the end of the year or during the first half of 2009.

Phil Smits, head of women’s healthcare at Bayer Schering Pharma, said: “Taking active pills for three additional days can result in a reduction of hormonal fluctuations which often occur with conventional 21/7 pills.”

He added that women who experienced headaches, cramps or other hormone withdrawal symptoms during the pill-free week would benefit from the features of drospirenone administered as part of the innovative dosing regimen for Yaz.

In May 2008, Bayer said it was “absolutely thrilled” with the pan-European marketing approval granted to Yaz.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.